Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14


Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.

Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2010 Jun;51(2):654-64. doi: 10.1016/j.neuroimage.2010.02.064. Epub 2010 Mar 2.


[Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy].

Ch├ętelat G, Desgranges B, Eustache F.

Rev Neurol (Paris). 2006 Oct;162(10):945-51. Review. French.


Long night's journey into the day: amyloid-╬▓ imaging in Alzheimer's disease.

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. Review.


[Current topics about mild cognitive impairment (MCI)].

Yamamoto Y.

Seishin Shinkeigaku Zasshi. 2011;113(6):584-92. Review. Japanese.


The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2010 May;6(3):202-11.e7. doi: 10.1016/j.jalz.2010.03.007. Review.


Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2010 May;6(3):239-46. doi: 10.1016/j.jalz.2010.03.006. Review.


Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM; The Alzheimer's Disease Neuroimaging Initiative..

Behav Neurol. 2009;21(1):3-12. doi: 10.3233/BEN-2009-0230. Review.


The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.

Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY.

Alzheimers Dement. 2015 Jul;11(7):757-71. doi: 10.1016/j.jalz.2015.05.001. Review.


Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment.

Apostolova LG, Thompson PM.

Neuropsychologia. 2008;46(6):1597-612. doi: 10.1016/j.neuropsychologia.2007.10.026. Epub 2007 Dec 14. Review.


The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding.

Beckett LA, Donohue MC, Wang C, Aisen P, Harvey DJ, Saito N; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2015 Jul;11(7):823-31. doi: 10.1016/j.jalz.2015.05.004. Review.


Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment.

Noble JM, Scarmeas N.

Int Rev Neurobiol. 2009;84:133-49. doi: 10.1016/S0074-7742(09)00407-3. Review.


Staging Alzheimer's disease progression with multimodality neuroimaging.

Ewers M, Frisoni GB, Teipel SJ, Grinberg LT, Amaro E Jr, Heinsen H, Thompson PM, Hampel H.

Prog Neurobiol. 2011 Dec;95(4):535-46. doi: 10.1016/j.pneurobio.2011.06.004. Epub 2011 Jun 22. Review.


Power calculations for clinical trials in Alzheimer's disease.

Ard MC, Edland SD.

J Alzheimers Dis. 2011;26 Suppl 3:369-77. doi: 10.3233/JAD-2011-0062. Review.

Supplemental Content

Support Center